# Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions

> **NCT05384691** · PHASE2 · RECRUITING · sponsor: **University of Leipzig** · enrollment: 213 (estimated)

## Conditions studied

- Myelodysplastic Syndromes
- Anemia

## Interventions

- **DRUG:** Luspatercept Injection

## Key facts

- **NCT ID:** NCT05384691
- **Lead sponsor:** University of Leipzig
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-27
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 213 (ESTIMATED)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05384691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05384691, "Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05384691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*